Dexcom Inc. Stock
Dexcom Inc. Stock
The Dexcom Inc. stock is trending slightly upwards today, with an increase of €0.16 (0.130%) compared to yesterday's price.
With 18 Buy predictions and not the single Sell prediction the community is currently very high on Dexcom Inc..
As a result the target price of 136 € shows a slightly positive potential of 13.33% compared to the current price of 120.0 € for Dexcom Inc..
For the coming years our community has positive and negative things to say abot the Dexcom Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of Dexcom Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dexcom Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dexcom Inc. | 0.130% | 1.525% | -7.374% | 9.784% | 7.038% | 62.605% | 360.215% |
| Dentsply Sirona Inc. | 0.580% | -1.664% | -14.106% | -30.370% | -19.204% | -53.786% | -46.792% |
| Teleflex Inc. | -2.130% | 0.538% | -10.096% | -17.982% | -17.257% | -45.000% | - |
| Baxter International | 0.110% | -3.488% | -15.819% | -15.509% | -5.264% | -53.351% | -51.898% |
Comments
DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Raymond James from $151.00 to $160.00. They now have a "strong-buy" rating on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at UBS Group AG from $153.00 to $163.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Citigroup Inc. from $148.00 to $161.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
News
DexCom (DXCM) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
DexCom (NASDAQ: DXCM)Q1 2024 Earnings CallApr 25, 2024, 4:30 p.m. ET
Operator
Source Fool.com
Dexcom Reports First Quarter 2024 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2024.
First Quarter 2024 Financial Highlights:
-
Revenue grew 24% year-over-year to
2 Growth Stocks to Buy Hand Over Fist in April
Earnings season, which is fast approaching, is often somewhat volatile for the stock market. Companies that overdeliver or fail to deliver can see their share prices move significantly overnight.